Indian Pediatrics

, Volume 51, Issue 3, pp 177–178 | Cite as

CFTR mutations in India: Need to do more! GENETICIST’S PERSPECTIVE



  1. 1.
    Kabra SK, Kabra M, Lodha R, Shastri S, Ghosh M, Pandey RM, et al. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. Indian Pediatr. 2003;40:612–619.PubMedGoogle Scholar
  2. 2.
    Ashavaid TF, Raghavan R, Dhairyawan P, Bhawalkar S. Cystic fibrosis in India: a systematic review. J Assoc Physicians India. 2012;60:39–41.PubMedGoogle Scholar
  3. 3.
    Kabra M, Ghosh M, Kabra SK, Khanna A, Verma IC. Delta F 508 molecular mutation in Indian children with cystic fibrosis. Indian J Med Res. 1996;104:355–358.PubMedGoogle Scholar
  4. 4.
    Sachdeva K, Saxena R, Puri R, Bijarnia S, Kohli S, Verma IC. Mutation analysis of the CFTR gene in 225 children: identification of five novel severe and seven reported severe mutations. Genet Test Mol Biomarkers. 2012;16:798–801.PubMedCrossRefGoogle Scholar
  5. 5.
    Sharma N, Singh M, Kaur G, Thapa BR, Prasad R. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet. 2009;73:26–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Kabra M, Kabra SK, Ghosh M, Khanna A, Arora S, Menon PS, et al. Is the spectrum of mutations in Indian patients with cystic fibrosis different? Am J Med Genet. 2000;93:161–163.PubMedCrossRefGoogle Scholar
  7. 7.
    Kapoor V, Shastri SS, Kabra M, Kabra SK, Ramachandran V, Arora S, et al. Carrier frequency of F508del mutation of cystic fibrosis in Indian population. J Cyst Fibros. 2006;5:43–46.PubMedCrossRefGoogle Scholar
  8. 8.
    Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7:S147–S150.PubMedCrossRefGoogle Scholar
  9. 9.
    Kawoosa MS, Bhat MA, Ali W, Hafeez I, Shastri S. Clinical and mutation profile of children with cystic fibrosis in Jammu and Kashmir. Indian Pediatr. 2014;51:185–189.CrossRefPubMedGoogle Scholar
  10. 10.
    Eckford PD, Li C, Ramjeesingh M, Bear CE. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylationdependent but ATP-independent manner. J Biol Chem. 2012;287:36639–36649.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevinek P, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365:1663–1672.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2014

Authors and Affiliations

  1. 1.Division of Medical Genetics, Department of Pediatrics Kasturba Medical CollegeManipal UniversityManipalIndia

Personalised recommendations